[1]Li YX,Coucke PA,Li JY,et al.Primary non-Hodgkin' s lymphoma of the nasal cavity:Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy[J].Cancer,1998,83(3):449-456.
[2]Cheung MM,Chan JK,Lau WH,et al.Early stage nasal NK/T cell lymphoma:Clinical outcome,prognostic factors,and the effect of treatment modality[J].Int J Radiat Oncol Biol Phys,2002,54(1):182-190.
[3]Grégoire V,Ang K,Budach W,et al.Delineation of the neck node levels for head and neck tumors:A 2013 update.DAHANCA,EORTC,HKNPCSG,NCIC CTG,NCRI,RTOG,TROG consensus guidelines[J].Radiother Oncol,2014,110(1):172-181.
[4]Kwong YL.Natural killer-cell malignancies:Diagbosis and treatment[J].Leukemia,2005,19(10):2186-2194.
[5]Lee J,Kim WS.Nasal-type NK/T cell lymphoma:Clinical features and treatment outcome[J].Br J Cancer,2005,92(7):1226-1230.
[6]Lee J,Suh C,Park YH,et al.Extranodal natural kill T-cell lymphoma,nasal-type:A prognostic model from a retrospective multicenter study[J].J Clin Oncol,2006,24(4):612-618.
[7]Thieblemont C,Coiffier B.Lymphoma in older patients[J].J Clin Oncol,2007,25(4):1916-1923.
[8]Ma HH,Qian LT,Pan HF,et al.Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma[J].Med Oncol.2010,27(3):798-806.
[9]Li CC,Tien HF,Yao M,et al.Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer T-cell or T-cell lymphoma[J].Cancer,2004,100(2):366-375.
[10]Kim SJ,Kim BS,Choi CW,et al.Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract[J].Leuk Lymphoma,2006,47(7):1265-1273.
[11]Kim GE,Lee SW,Chang SK,et al.Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck[J].Radiother Oncol,2001,61(1):261-269.
[12]Jaccard A,Gachard N,Marin B,et al.Efficacy of L-asparaginase with methotrexate and dexamethasone(AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma,a phase 2 study[J].Blood,2011,117(6):1834-1839.